GENI vs TBLA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 22, 2026

GENI

47.0
AI Score
VS
GENI Wins

TBLA

29.7
AI Score

Investment Advisor Scores

GENI

47score
Recommendation
HOLD

TBLA

30score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric GENI TBLA Winner
Forward P/E 46.9484 90.0901 GENI
PEG Ratio 0 0 Tie
Revenue Growth 64.7% 2.4% GENI
Earnings Growth 0.0% 77.1% TBLA
Tradestie Score 47.0/100 29.7/100 GENI
Profit Margin -23.0% 6.0% TBLA
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL GENI

Relative Price Performance (Last 90 Days)

GENI 1M: -18.9% · 3M: -9.1% TBLA 1M: -15.4% · 3M: -41.6%

Current Technical Phase

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.9 · Price: $6.02

TBLA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.1%), weak momentum, RSI 28

RSI (14): 27.8 · Price: $3.23

Fundamentals Snapshot

Metric GENI TBLA
Market Cap — —
Forward P/E 5.6 10.2
Trailing P/E — 8.7
Revenue (TTM) — —
Revenue Growth 0.6% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin -0.1% 0.0%
EPS -0.66 0.38
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.